药物遗传变异与Fluoxetine相关的药物动力学来自健康受试者的生物等价性研究
Carlos Alejandro Díaz-Tufinio1,2, José Antonio Palma-Aguirre2, Vanessa Gonzalez-Covarrubias3
1Tecnologico de Monterrey, School of Engineering and Sciences, Mexico City 14380, Mexico.
Journal of personalized medicine
|September 28, 2023
概括
这项研究将fluoxetine药物反应的变异性与关键代谢基因 (如CYP2D6.6) 的遗传变异联系起来. 了解这些药物遗传学关联可以帮助个性化抗抑郁药物治疗,以获得更好的患者结果.
科学领域:
- 药物基因组学 药物基因组学
- 临床药理学 临床药理学
- 分子遗传学 分子遗传学
背景情况:
- 广泛使用的抗抑郁药Fluoxetine在患者反应中表现出显著的个体间变异性.
- 这种变异在很大程度上归因于其被多态细胞染色体P450 2D6 (CYP2D6) 酶代谢,导致血度的差异.
- 确定影响素药理动学的遗传因素对于优化治疗疗效和安全至关重要.
研究的目的:
- 调查药物遗传变异与素的药物动力学概况之间的关联.
- 为了识别特定的单核酸变体 (SNVs),影响素代谢和反应.
- 为更广泛地了解个性化抗抑郁药疗法的基因型-表型关联做出贡献.
主要方法:
- 一个生物等价性交叉试验,涉及24名健康受试者接受fluoxetine 20 mg囊.
- 在剂量后72小时内采集血液样本,以确定fluoxetine的度.
- 使用候选基因方法对受试者进行基因定型,以识别SNV并将其与PK参数关联.
主要成果:
- 弗洛克塞丁配方的生物等价性得到证实.
- 在10个基因中的34个SNV被发现显著影响素PK.
- 在细胞染色体P450基因 (CYPs) 中发现了29个SNV,包括CYP2D6和CYP2C19,在影响药理学的基因中发现了5个SNV (SLC6A4,TPH1,ABCB1).
- 在CYP2D6和CYP2C19中降低/无功能的SNV被表型证实.
结论:
- 药物遗传变异,特别是在CYP基因中,显著影响fluoxetine的药理动力学.
- 富洛素代谢的基因型-表型关联为个性化抗抑郁药物治疗策略提供了基础.
- 这项研究增强了药物遗传学知识,为更合理,更有效的抗抑郁药物处方铺平了道路.
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
186
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
186
Bioequivalence: Overview
1.1K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.1K
Factors Affecting Drug Biotransformation: Biological
172
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
172
Factors Affecting Protein-Drug Binding: Patient-Related Factors
73
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
73
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
272
A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in...
The drug's acidity or basicity is essential in...
272


